Back to top

JOINT DEVELOPMENT AGREEMENT

Development Agreement

JOINT DEVELOPMENT AGREEMENT | Document Parties: QUICK MED TECHNOLOGIES INC | Molnlycke Health Care AB You are currently viewing:
This Development Agreement involves

QUICK MED TECHNOLOGIES INC | Molnlycke Health Care AB

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: JOINT DEVELOPMENT AGREEMENT
Date: 4/9/2008

JOINT DEVELOPMENT AGREEMENT, Parties: quick med technologies inc , molnlycke health care ab
50 of the Top 250 law firms use our Products every day
 
                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                    EXHIBIT 10.1
JOINT DEVELOPMENT AGREEMENT

This Joint Development Agreement (“JDA”) is entered into as of March 19, 2008 (“Effective Date”) by and between Molnlycke Health Care AB , a corporation incorporated under the laws of Sweden, with a principal place of business in Gothenburg, Sweden (“MHC”) and Quick-Med Technologies, Inc. , a Nevada corporation, having its principal office at 902 NW 4 th Street, Gainesville, Florida 32601 (hereinafter referred to as “QMT”).

WHEREAS

-  
QMT is engaged inter alia in the development of technologies related to medical health care applications.

-  
MHC is interested in incorporating QMT’s Quick-Med Technology into certain ***** products manufactured by MHC.

-  
QMT is willing to grant to MHC licenses (the “ Licenses ”) to use certain Know-how and Patent(s), which is the subject of ongoing negotiations concerning a license agreement for same.

-  
The Parties wish to commence with the tasks and responsibilities described in the so-called Joint Development Agreement (“JDA”), which is attached hereto as Attachment – JDA1.

 
NOW THEREFORE the Parties hereto hereby agree as follows.


1.            Performance of JDA .  The parties agree to perform in accordance with the terms of the JDA, as set forth in Attachment – JDA1, commencing immediately, and MHC agrees to pay the sums set forth in the JDA when they become due and owing as provided in the JDA.  For the purpose of clarity, the performance of the JDA by both Parties is understood as being an integral part of an ongoing cooperative project aimed at resulting in a commercially viable technology to be incorporated in the certain MHC products under a global technology license.  However, by entering into this JDA, both Parties acknowledge and understand that neither Party is obligated to enter into any other or further Agreement between each other.

2.            Term .  This JDA shall remain in force until 30 June 2008 or until the Parties sign a License Agreement covering the Know-how and Patents that are the subject of this JDA, whichever is first.

3.            Results from JDA .  The information, data, results, reports, deliverables and other outputs or outcomes from the performance of the JDA shall be jointly owned by both Parties during the term of the JDA, and shall be considered Confidential Information.
 
4.            Confidentiality .

4.1.           Unless otherwise agreed in writing, the Parties specifically covenant and agree to hold all Confidential Information, and any records and documents containing Confidential Information, in the strictest confidence, and will not disclose, divulge or reveal Confidential Information to any person or persons whomsoever other than (a) to its employees as necessary and appropriate for the exclusive purpose of enabling such employees to perform their ordinary, day-to-day duties associated with performing QMT’s work for or directly related to MHC; or (b) as specifically authorized by the non-disclosing Party in writing.

4.2.           “Confidential Information” as used herein means ideas, designs, records, plans, drawings, intellectual property, products, product samples, processes, systems, documents, writings, manuals, inventions, discoveries, formulae, prices, price lists, practices,   business plans, business methods, trade secrets, and all other information designated by the Parties individually or jointly to be “Confidential Information” (in writing, orally, or otherwise), with the sole exception of information available to the general public, without restriction.
 

***** This material has been omitted pursuant to a request for confidential treatment and filed separately with the Securities and Exchange Commission.

 
- 1 -

 

 
5.            Cooperation .  If applicable, QMT shall provide reasonable cooperation with MHC in preparing and filing any patent applications on the MHC Technology.

6.            Independent Contractors .  When performing under this JDA, QMT and MHC shall act at all times as independent parties.  Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between QMT and MHC.  Neither party sha

 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more